Trademarkia Logo

Canada

C$
Trademark Search in Canada
SANTHERA

View On IC.GC.CA

SANTHERA
REGISTERED

on 15 Dec 2010

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

Santhera Pharmaceuticals Holding AG

Hohenrainstrasse 244133 Pratteln

CH

Serial Number

1371548 filed on 13th Nov 2007

Registration Number

TMA784974 registered on 15th Dec 2010

Registration expiry Date

15th Dec 2025

Correspondent Address

GOODMANS LLP

ATTN: INTELLECTUAL PROPERTY GROUPBAY ADELAIDE CENTRE333 BAY STREET, SUITE 3400TORONTO

ONTARIO

CA

M5H2S7

SANTHERA

Trademark usage description

pharmaceutical preparations for the treatment of neurological diseases and neuromuscular junction disorders. pharmaceutical preparations for the prev Read More

Classification Information

Class [005]
Biological preparations for medical diagnosis of and pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely diseases encompassing motor neuron disease, peripheral nervous system diseases, movement disorders and muscular diseases namely ataxia, cervical dystonia, chorea , dystonia , Huntington's disease, multiple system atrophy, myoclonus, Parkinson's disease, Parkinsonism, progressive supranuclear palsy, restless legs syndrome, tardive dyskinesia, Tourette syndrome, tremor and Wilson's disease, biological preparations for medical diagnosis of and pharmaceutical preparations for the immune system, namely, autoimmune diseases, immunologic deficiency syndromes, biological preparations for medical diagnosis of and pharmaceutical preparations for the treatment of cardio-vascular diseases, biological preparations for medical diagnosis of and pharmaceutical preparations for the metabolic system namely, for the treatment of diabetes, biological preparations for medical diagnosis of and pharmaceutical preparations for the treatment of the respiratory system, biological preparations for medical diagnosis of and pharmaceutical preparations for the treatment of the musculoskeletal system, muscular diseases and neuromuscular diseases, namely muscle weakness, fasciculation, muscle atrophy spasm myokymia, muscle hypertonia, myalgias, and muscle hypotonia, all forms of ataxia, all forms of muscular dystrophy, Lou Gehrig's disease, Parkinson disease, Huntington disease, spinal muscular atrophies, inherited or acquired peripheral polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, all forms of myotonia and all inherited or acquired myopathy, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, muscular dystrophies, amyotrophia, atrophy, spinal muscular atrophies, biological preparations for medical diagnosis of and pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; oral contraceptives, biological preparations for medical diagnosis of and pharmaceutical preparations for use in ophthalmology; biological preparations for medical diagnosis of and pharmaceutical preparations for use in gastroenterology, biological preparations for medical diagnosis of and pharmaceutical preparations for the prevention and treatment of ocular disorders; anti-invectives, anti-bacterials, antivirals, antibiotics, anti-fungals, human vaccines; diagnostic preparations for medical laboratory use, biological preparations for medical diagnosis of and pharmaceuticals for the treatment of neurological diseases namely Lou Gang's disease and Huntington's disease, ophthalmologic preparations, muscle wasting, cardiornyopathies, optic nerve degradation, biological preparations for medical diagnosis of and ophthalmology pharmaceutical preparations for the treatment of neurological diseases, namely, Lou Gehrig's disease and Huntington's disease, ophthalmology preparations, muscle wasting, cardiomyopathies, optic nerve degradation, memory loss, biological preparations for medical diagnosis of and pharmaceutical preparations for the treatment of polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia; reagents for medical diagnostic use; biological preparations for medical diagnostic purposes; medical diagnostic reagents, diagnostic preparations for medical laboratory use

Classification kind code

11

Class [042]
Services in the field of scientific and industrial research, namely computer programming for these purposes, particularly in the fields of cell cultures, cellular test systems for evaluating drugs, antibodies, test systems for detecting pharmacologically active compounds, animal models for neuro-muscular and ophthalmological diseases, medical patient monitoring, chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use, and providing information in the field of scientific, laboratory or medical research

Classification kind code

11

Mark Details

Serial Number

1371548

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 4th Dec 2009		Allowed
Submitted for opposition 42
on 19th Aug 2009		Advertised
Submitted for opposition 26
on 13th Aug 2009		Approved
Submitted for opposition 27
on 22nd Jun 2009		Approval Notice Sent
Submitted for opposition 12
on 18th Nov 2008		Extension of Time
Submitted for opposition 20
on 3rd Jul 2008		Examiner's First Report
Submitted for opposition 22
on 27th Jun 2008		Search Recorded
Submitted for opposition 30
on 13th Nov 2007		Filed
Submitted for opposition 1
on 13th Nov 2007		Created
Submitted for opposition 31
on 13th Nov 2007		Formalized